{
  "schema": "vedokrok.public-item.v1",
  "release_id": "VEDOKROK-SEL-5d86e1b23401e578",
  "url": "/knowledge/was-safety-measured-or-merely-not-mentioned",
  "id": "MHC-D-RESEARCH-0067",
  "version": "0.1.0",
  "title": "Was safety measured, or merely not mentioned?",
  "summary": "Silence has no sample size.",
  "kind": "question",
  "body": "Which adverse outcomes were actively collected, for how long and in how many people?\n\nCould this design detect uncommon, delayed or population-specific problems?",
  "limits": [
    "Do not infer that an unreported harm occurred. Separate missing evidence, observed events and a demonstrated causal risk."
  ],
  "topics": [
    "critical-thinking"
  ],
  "intents": [],
  "source_ids": [
    "cochrane-evidence-certainty"
  ],
  "evidence": [
    {
      "claim": "Important harms may require evidence beyond short efficacy trials and should not disappear from the question.",
      "source_id": "cochrane-evidence-certainty",
      "role": "supports",
      "note": "Claim basis: guidance. Claim limit: A missing harm report is neither proof of safety nor proof that a harm occurred.\nSource access: selected_html_passages; accessed on: 2026-09-17; inspected sections: [\"14.1.1-14.1.2\", \"14.2.1\", \"14.2.2 indirectness and imprecision\"].\nSource note: GRADE ratings belong to bodies of evidence for specified outcomes; the corpus does not assign new GRADE ratings through these cards.\nAgent scope review: Cochrane 14.1.2 includes benefits and harms among outcomes important to readers. Its adverse-effects section also discusses insufficient detection in small trials and the need for separate evidence on uncommon or long-term harms. The example does not infer a harm from silence.",
      "locator": "14.1.2, selecting benefit and harm outcomes"
    }
  ],
  "use_when": [
    "A study with no prominent harm result is described as proof of complete safety."
  ],
  "avoid_when": [
    "Do not infer that an unreported harm occurred. Separate missing evidence, observed events and a demonstrated causal risk."
  ],
  "question": "Which adverse outcomes were actively collected, for how long and in how many people?\n\nCould this design detect uncommon, delayed or population-specific problems?",
  "example": "A short, small trial reports task performance but says little about unwanted effects. Its duration cannot establish what happens after years of use.",
  "check": "Does the safety claim stay within what was observed and could reasonably be detected?",
  "published_at": "2026-11-12T17:42:00Z",
  "review": {
    "kind": "agent",
    "label": "Agent editorial and scoped source review",
    "reviewed_at": "2026-11-12T17:42:00Z"
  },
  "knowledge_origin": {
    "release_id": "MHC-RPUB-20261112-07d31a69",
    "corpus_commit": "07d31a6904d38f9fe2189aee7b26bb065724b120",
    "manifest_sha256": "d676e87a17b9210d8037fd74c3f1ea735debd384fa069ba127a87ad441aa4f20",
    "projection_sha256": "7e7900a14145b4d025c2279ceb005ff3633adb88263038886b09282e4dafb04b",
    "published_at": "2026-11-12T17:42:00Z"
  },
  "editorial_overlay": null,
  "editorial": null,
  "notices": [],
  "sources": [
    {
      "id": "cochrane-evidence-certainty",
      "title": "Chapter 14: Completing Summary of findings tables and grading the certainty of the evidence",
      "url": "https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-14"
    }
  ],
  "relations": [
    {
      "from": "MHC-D-RESEARCH-0067",
      "to": "MHC-D-RESEARCH-0071",
      "type": "useful_with",
      "url": "/knowledge/keep-evidence-certainty-attached-to-its-outcome"
    }
  ],
  "collections": [
    {
      "id": "RC-RESEARCH-READ-STUDY-BEHIND-PROMISE",
      "title": "Read the study behind the promise",
      "url": "/collections/read-the-study-behind-the-promise"
    }
  ],
  "topic_hubs": [
    {
      "id": "critical-thinking",
      "title": "Critical thinking and evidence",
      "url": "/topics/critical-thinking"
    }
  ],
  "solution_packs": []
}
